GLYCOMIMETICS INC (GLYC) Current Income Tax Expense (Benefit) USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Glycomimetics Inc quarterly/annual Current Income Tax Expense (Benefit) history and growth rate from 2016 to 2024.
  • Glycomimetics Inc Current Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
Current Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q1 2020 $0 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-01
Q1 2019 $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q1 2018 $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2017 $0 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q1 2016 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.